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Electrospinning is used to produce fibers in the nanometer range by stretching a polymeric jet using 
electric fields of high magnitude. Chitosan is an abundant natural polymer that can be used to obtain 
biocompatible nanostructured membranes. The objectives of this work were to obtain nanostructured 
membranes based on blends of chitosan and polyoxyethylene (PEO), and evaluate their thermal and 
morphological properties, as well as their in vitro biocompatibility by agar diffusion cytotoxicity 
tests for three different cell lines. A nanostructured fibrous membrane with fiber diameters in the 
order of 200 nm was obtained, which presented a rough surface and thickness ranging from one to 
two millimeters. The results of the cytotoxicity tests evidenced that the chitosan/PEO membranes 
are non-toxic to the cells studied in this work. Further, the electrospinning technique was effective 
in obtaining nanostructured chitosan/PEO membranes, which showed biocompatibility according to 
in vitro preliminary tests using the cell lines.
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1. Introduction
Polymeric nanofibers can be produced using many 
different techniques, such as phase separation, self-assembly 
and electrospinning1. Electrospinning is the only technique 
that allows dimensional control, fiber formation in different 
arrangements, use of several polymers and production 
in great quantities compared to the other methods2. This 
technique is based on the application of high magnitude 
electric potentials (5-50 kV) and low current (0.5-1 µA) in 
which a jet of fluid material is accelerated and stretched, 
producing fibers of reduced diameter3-5.
Chitosan is derived from chitin deacetylation and 
is a natural polymer that is suited for electrospinning in 
order to produce nanostructured fibrous mats. Usually, 
the electrospinning of chitosan requires blending this 
polymer with other biocompatible synthetic polymers such 
as PEO. Chitosan has been used for many years in tissue 
regeneration6, in some drug delivery controlled systems7, for 
covering wounds and for other biomedical devices. Several 
studies have shown the chitosan biocompatibility in different 
forms (membranes, gel, composites, films and matrices). 
Therefore, there is an increasing interest in the production 
of chitosan-based nanostructured biomaterials8-11.
A biomaterial should be biocompatible and present 
an appropriate response for a specific situation, causing 
minimum allergic, inflammatory and toxic reactions 
when in contact with live tissues or organic fluids12. The 
normative instruction number 10993 from the International 
Standard Organization describes that in vitro assays are 
normally done as screening tests in the first phase of 
the biocompatibility evaluation. The in vitro evaluation 
can supply fast and financially accessible results about 
biological interactions and decrease the use of animals in 
research13. Cytotoxicity tests are done in vitro and evaluate 
the toxic effect for the cells of some materials, which can be 
cell death, changes in membrane permeability, enzymatic 
inhibition, etc. This technique uses cell culture and the 
toxicity can be measured quantitatively by cell lysis (cell 
death), inhibition of cell growth and other effects caused by 
the devices, materials and extracts. The cells used to make 
cultures are acquired from previously established lines and 
supplied by resellers of biological products or cell and tissue 
banks, such as the American Tissue Culture Collection 
(ATCC) due to the high reproducibility, efficiency and 
availability14-15.
DOI: 10.1590/S1516-14392012005000013
Materials Research. 2012; 15(2): 213-217 © 2012
Vulcani et al.
The objective of this study was to obtain nanostructured 
membranes of Chitosan/Peo using the electrospinning 
technique. The membrane characterization was performed 
by its thermal and morphological characteristics and the 
evaluation of their biocompatibility was achieved by using 
the agar diffusion method to assess the cytotoxicity of the 
membranes in three cell lines.
2. Materials and Methods
2.1. Membrane preparation
The membranes were prepared by chitosan of medium 
molecular weight with deacetylation degree of 80% and 
viscosity of 284 cps obtained from Aldrich®, glacial acetic 
acid PA from Synth® and poly ethylene oxide (PEO), 
900,000 g.mol–1, also from Aldrich®. All materials were used 
as received and the deionized water was used to compose 
the solvent system.
The electrospinning equipment used to obtain chitosan/PEO 
membranes was built at the “Escola de Engenharia Química do 
Departamento de Tecnologia de Polímeros da Universidade 
de Campinas* (UNICAMP), Campinas, SP, Brazil” with the 
following components: high voltage power supply, a 10 ml glass 
syringe (Luer lock inlet) containing a stainless steel needle with 
internal diameter of 1 mm, an electrode, a sustaining claw for 
the syringe (connected to a sustaining support for the claw), a 
grounded-aluminum-collector and a rotary-device (≈80 rpm) 
constituted by a 3.2 cm diameter stainless steel tube between 
the capillary and the collect table16-19.
Membranes were made by the electrospinning technique 
according to the methodology described by Bizarria et al. 
(2009)19 using the setup described in the previous paragraph 
and the blend composed by three parts of a 4% (w.w–1) chitosan 
solution and one part of a 3% (w.v–1) PEO solution, resulting 
in a final concentration of approximately 80% chitosan and 
20% PEO. This blend composition was selected to make the 
membranes because, among the solution blends that showed 
good processing conditions, in the referred previous study, it 
was the one with greatest chitosan concentration.
Preparing the 4% (w.w–1) chitosan solution, an aqueous 
solution with high concentration of acetic acid 90% (v.v–1) 
was used as solvent. The chitosan solution was left under 
magnetic stirring (not being removed) until its complete 
homogenization, which took a few days. The 3% (w.v–1) 
PEO solution was prepared under magnetic stirring using 
deionized water as solvent. To prepare the blend solution to 
be electrospun, a part of the 3% PEO solution (by volume) 
was added to 3 parts (by weight) of the 4% chitosan solution. 
The resulting blend was left under magnetic stirring for 
two hours before being electrospun. The preparation of the 
solutions, as well as the preparation of the blend solution and 
its electrospinning process were run at room temperature. 
The flow rate was determined by the viscosity of the solution 
being approx. 1 mL/h. and the distance between the needle 
tip to collector cylinder 7.5 cm at an applied voltage of 20 kV.
2.2. Membrane characterization
Scanning electron microscopy (SEM) was carried out 
on a JEOL model JXA-840 A apparatus at an accelerating 
* School of Chemical Engineering of the Polymer Technology Department 
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voltage of 25 kV. All samples were sputtered with gold prior 
an high magnitude electric potentials alysis.
Differential scanning calorimetry (DSC) was performed 
under N2 flow rate of 50 mL/min, in a DSC 2920 apparatus 
from TA Instruments, under a heating rate of 10 °C/min, in 
the temperature range between –100 and 250 °C.
2.3. Cell culture
The assays were performed at the “Instituto de Química 
de São Carlos da Universidade de São Paulo**** (USP), 
São Carlos, SP, Brazil” using the cell lines HEp-2 (human 
larynx carcinoma), VERO (African green monkey kidney 
cells) and McCoy (mouse fibroblasts) at the concentration 
of 3.0 × 105 cells.mL–1. The cells were grown in Petri 
(60 × 15 mm) dishes with a volume of 5 mL of ISCOVE’s 
medium by 24 hours. After this period, the culture medium 
was removed and discarded, and 5 mL of a (1:1) mixture 
composed by ISCOVE’s medium and agar 1.8% containing 
0.01% of neutral red were added15.
2.4. Cytotoxicity evaluation using the agar 
diffusion method
Fragments of the membrane measuring about 0.25 cm2 
of superficial area were placed on agar before their complete 
solidification. The Petri dishes were kept in the cell incubator 
with 5% CO2 at 37 °C during 24 hours.
Latex fragments were used as positive control and 
confirmedly non-toxic filter paper discs as negative control, 
respecting the dimension of the superficial area. The plates 
were analyzed macroscopically and microscopically using 
the halo presence and the cell integrity around the sample 
as parameters, respectively15.
3. Results
3.1. Macroscopic and microscopic 
characteristics of chitosan/PEO membranes
Visual and manual inspections evidenced that the 
membranes obtained had rough aspect and were very thin, 
with about one to two millimeters thickness. Figure 1 shows 
the photograph of the membrane fragment.
** Chemistry Institute of São Carlos of the University of São Paulo.
Figure 1. Fragment of the chitosan membrane obtained by 
electrospinning. Notice the rough surface and the low thickness.
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Figure 2 shows, in different magnitudes, SEM images 
of an 80% chitosan/20% PEO membrane obtained by 
electrospinning process in which it is possible to observe a 
non-woven structure composed of fibers whose diameters 
range between the submicron and nanoscale.
3.2. Thermal properties
The DSC curves are presented in Figure 3. The pure 
chitosan DSC curve shows only a single thermal event 
corresponding to the dehydration of chitosan, while the 
DSC curve of pure PEO also shows only one endothermic 
event with its peak at approx. 70 °C, which refers to the 
crystalline melt of the pure PEO. Finally, the thermogram of 
the blend of chitosan/PEO presents two endothermic events, 
which show their maximum intensities at the temperatures of 
PEO melting and dehydration of chitosan. Hence it can be 
concluded that the blend preparation and the electrospinning 
process did not affect significantly the thermal properties of 
their two original components.
3.3. In vitro biocompatibility evaluation
The toxicity using the agar diffusion method is 
evidenced by the presence of a halo around the material 
tested. This halo is observed when cell lysis occurs, releasing 
the neutral red staining incorporated by cells and giving a 
transparent appearance to the area15.
The results of the cytotoxicity tests with the membrane 
prepared with cell lines showed that the three cell lines did 
not present halo formation around the fragments of chitosan 
nanostructured membrane similarly to the negative controls, 
suggesting that the material is not cytotoxic to fibroblasts and 
epithelial cells (Figures 4, 5 and 6). The use of three lines 
originated from human, monkey and mouse cells reinforce 
the large applicability of the membrane prepared since it 
demonstrated to be biocompatible in all cases.
This non-toxic characteristic of the chitosan was 
observed by Amaral et al. (2006)20, who submitted blends 
of collagen and chitosan to the same in vitro cytotoxicity 
tests, i.e., the agar diffusion method. Despite the fact 
that the chitosan membrane used by that author was not 
nanostructured, their result corroborates with the present 
material biocompatibility findings. Similarly, Asia et al. 
(2006)21 verified the in vitro biocompatibility of chitosan 
films by submitting them to human fibroblast cultures and 
concluded that their substance was non-toxic and could 
be used as a biomaterial. Oliveira et al. (2008)22 submitted 
chitosan samples in diverse concentrations to in vitro 
cytotoxicity tests and confirmed that changes in chitosan 
concentrations did not affect the non-toxic characteristic 
of the material, however, pH variations of the formulations 
caused cell lysis. Brito et al. (2009)23 implanted chitosan 
membranes in the subcutaneous of rats for biocompatibility 
evaluation and observed a little inflammatory reaction with 
fibrosis formation (pseudocapsule) around the samples. 
The authors stated that the characteristics observed allow 
to consider that the material can be used for tissue repair. 
In another study24, nanostructured chitosan composites 
were used as a growth matrix for human fibroblasts. The 
authors verified that the presence of nanostructured chitosan 
favored the cell proliferation, imitating the extracellular 
matrix properly. These results are similar to those found by 
Brito et al.23 using collagen and chitosan nanostructured 
membranes as a growth matrix for human fibroblasts 
verifying the non-toxic characteristic for cells. The authors 
of that study also used the composites in animals to verify 
the effectiveness on skin healing, and concluded that 
the composite showed better results when compared to 
commercially available collagen membranes.
Figure 2. SEM images of 80% chitosan/20% PEO membranes, a) 300 × magnification; b) 5,000 × magnification; and c) 20,000 × 
magnification.
Figure 3. DSC of pure chitosan, pure PEO and of the 80% 
chitosan/20% PEO blend membrane.
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Figure 4. Digital photograph of the Petri dishes containing the cell line HEp-2 (human larynx carcinoma) and the sample of the 
nanostructured chitosan membrane (a), positive control using latex (b) and negative control using filter paper (c). The halo formation was 
observed just around the positive control (arrow) demonstrating that the chitosan nanostructured samples are not cytotoxic.
Figure 5. Digital photograph of the Petri dishes containing the cell line Vero (African green monkey kidney cells) and the sample of 
nanostructured chitosan membrane (a), positive control using latex (b) and negative control using filter paper (c). The halo formation was 
observed just around the positive control (arrow) demonstrating that the chitosan nanostructured samples are not cytotoxic.
Figure 6. Digital photograph of the Petri dishes containing the cell line McCoy (mouse fibroblasts) and the sample of the nanostructured 
chitosan membrane (a), positive control using latex (b) and negative control using filter paper (c). The halo formation was observed just 
around the positive control (arrow) demonstrating that the chitosan nanostructured samples are not cytotoxic.
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In this way, the results presented in this paper agree 
with results reported previously with chitosan membrane 
that suggest that the material is biocompatible.
4. Conclusion
Chitosan/PEO biocompatible fibrous mats were 
successfully obtained by electrospinning. A non-woven 
structure with fiber diameter on the nanometer range was 
observed by SEM. Results from DSC have shown that 
the electrospinning process did not affect significantly 
the original thermal properties of both chitosan and PEO. 
The agar diffusion method applied for three different cell 
lines, that is, HEp-2 (human larynx carcinoma cells), Vero 
(African green monkey kidney cells) and McCoy (mouse 
fibroblasts cells) proved the biocompatibility of the chitosan 
electrospun membrane, which makes it suitable for further 
in vivo tests.
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